Page 126 - GPD-4-2

Gene & Protein in Disease Pediatric glioma circadian clock genes

25. Hwang-Verslues WW, Chang PH, Jeng YM, et al. Loss of molecular subgroups and recurrent activating ACVR1
corepressor PER2 under hypoxia up-regulates OCT1-mediated mutations. Nat Genet. 2014;46(5):451-456.
EMT gene expression and enhances tumor malignancy. Proc doi: 10.1038/ng.2936
Natl Acad Sci U S A. 2013;110(30):12331-1236.
37. Griesinger AM, Birks DK, Donson AM, et al. Characterization
doi: 10.1073/pnas.1222684110
of distinct immunophenotypes across pediatric brain tumor
26. Das V, Bhattacharya S, Chikkaputtaiah C, Hazra S, Pal M. types. J Immunol. 2013;191(9):4880-4888.
The basics of epithelial-mesenchymal transition (EMT):
A study from a structure, dynamics, and functional doi: 10.4049/jimmunol.1301966
perspective. J Cell Physiol. 2019;234:14535-14555. 38. Gump JM, Donson AM, Birks DK, et al. Identification of
targets for rational pharmacological therapy in childhood
doi: 10.1002/jcp.28160
craniopharyngioma. Acta Neuropathol Commun. 2015;3:30.
27. Bowman RL, Wang Q, Carro A, Verhaak RG, Squatrito M.
GlioVis data portal for visualization and analysis of brain doi: 10.1186/s40478-015-0211-5
tumor expression datasets. Neuro Oncol. 2017;19(1):139-141. 39. Cancer Genome Atlas Research Network. Comprehensive
genomic characterization defines human glioblastoma genes
doi: 10.1093/neuonc/now247
and core pathways. Nature. 2008;455(7216):1061-1068.
28. Wang Z, Chen G. Insights about circadian clock in glioma:
From molecular pathways to therapeutic drugs. CNS doi: 10.1038/nature07385
Neurosci Ther. 2022;28(12):1930-1941. 40. Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA,
Buetow K. Rembrandt: Helping personalized medicine
doi: 10.1111/cns.13966
become a reality through integrative translational research.
29. Chan P, Rich JN, Kay SA. Watching the clock in glioblastoma. Mol Cancer Res. 2009;7(2):157-167.
Neuro Oncol. 2023;25(11):1932-1946.
doi: 10.1158/1541-7786.MCR-08-0435
doi: 10.1093/neuonc/noad107
41. Gravendeel LA, Kouwenhoven MC, Gevaert O, et al. Intrinsic
30. Lambert SR, Witt H, Hovestadt V, et al. Differential gene expression profiles of gliomas are a better predictor of
expression and methylation of brain developmental genes survival than histology. Cancer Res. 2009;69(23):9065-9072.
define location-specific subsets of pilocytic astrocytoma.
Acta Neuropathol. 2013;126(2):291-301. doi: 10.1158/0008-5472.CAN-09-2307
doi: 10.1007/s00401-013-1124-7 42. Kamoun A, Idbaih A, Dehais C, et al. Integrated multi-
omics analysis of oligodendroglial tumours identifies three
31. Dias SF, Richards O, Elliot M, Chumas P. Pediatric-like brain subgroups of 1p/19q co-deleted gliomas. Nat Commun.
tumors in adults. Adv Tech Stand Neurosurg. 2024;50:147-183. 2016;7:11263.
doi: 10.1007/978-3-031-53578-9_5 doi: 10.1038/ncomms11263
32. Kool M, Koster J, Bunt J, et al. Integrated genomics identifies 43. Murat A, Migliavacca E, Gorlia T, et al. Stem cell-related
five medulloblastoma subtypes with distinct genetic profiles, “self-renewal” signature and high epidermal growth
pathway signatures and clinicopathological features. PLoS factor receptor expression associated with resistance to
One. 2008;3(8):e3088. concomitant chemoradiotherapy in glioblastoma. J Clin
doi: 10.1371/journal.pone.0003088 Oncol. 2008;26(18):3015-3024.
33. Honma S, Kawamoto T, Takagi Y, et al. Dec1 and Dec2 doi: 10.1200/JCO.2007.15.7164
are regulators of the mammalian molecular clock. Nature. 44. Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of
2002;419(6909):841-844. tumor-infiltrating immune cells. Nucleic Acids Res.
doi: 10.1038/nature01123 2020;48(W1):W509-W514.
34. Green CB, Takahashi JS. Xenobiotic metabolism in the fourth doi: 10.1093/nar/gkaa407
dimension: PARtners in time. Cell Metab. 2006;4(1):3-4. 45. Cavalli FMG, Remke M, Rampasek L, et al. Intertumoral
doi: 10.1016/j.cmet.2006.06.002 heterogeneity within medulloblastoma subgroups. Cancer
Cell. 2017;31(6):737-754.e6.
35. Kubo M. Diurnal rhythmicity programs of microbiota and
transcriptional oscillation of circadian regulator, NFIL3. doi: 10.1016/j.ccell.2017.05.005
Front Immunol. 2020;11:552188.
46. Robinson G, Parker M, Kranenburg TA, et al. Novel
doi: 10.3389/fimmu.2020.552188 mutations target distinct subgroups of medulloblastoma.
Nature. 2012;488(7409):43-48.
36. Buczkowicz P, Hoeman C, Rakopoulos P, et al. Genomic
analysis of diffuse intrinsic pontine gliomas identifies three doi: 10.1038/nature11213

Volume 4 Issue 2 (2025) 20 doi: 10.36922/gpd.4112